In 2024, Amplitude Surgical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Amplitude Surgical has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Amplitude Surgical’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions of Amplitude Surgical amounted to 172 metric tons of CO2 equivalent. This figure reflects indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Amplitude Surgical increased by 91.11%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2024, Amplitude Surgical reported Scope 2 greenhouse gas (GHG) emissions of 172 tCO₂e without specifying the calculation method. a
Since 2022, Amplitude Surgical's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 54.95%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), Amplitude Surgical's Scope 2 emissions (Unspecified Calculation Method) rose by 91.11% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
In 2024, Amplitude Surgical reported its Scope 2 emissions using an unspecified methodology. a
In 2024, Amplitude Surgical reported 226 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Amplitude Surgical includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2024, Amplitude Surgical reported total Scope 3 emissions of 226 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
Since 2022, Amplitude Surgical's Scope 3 emissions have increased by 10.24%, reflecting a rising long-term trend in Scope 3 emissions over time. a
Compared to the previous year (2023), Amplitude Surgical's Scope 3 emissions increased by 15.9%, suggesting that the company faced challenges in reducing emissions across its value chain. a
In 2024, Amplitude Surgical reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol. a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to Amplitude Surgical's Scope 3 emissions were: a